PremiumRatingsAgilon Health: Hold Rating Amid Positive Results and Cost Concerns Agilon Health Reports Q1 2025 Financial Results Agilon Health reports Q1 EPS 0c, consensus 1c PremiumThe FlyAgilon Health upgraded to Buy from Neutral at Citi MCOs’ ‘mixed messages’ creating volatility in value-based care, says Truist Agilon Health falls -37.8% PremiumThe FlyAgilon Health price target lowered to $5 from $6 at Baird Agilon Health downgraded to Neutral from Outperform at Baird Agilon Health Stock (AGL) Rally’s Over 42% This Week on Analyst Upgrade 
